Has Angie Osborn received payments from drug or device companies?

Yes. Drug and device makers reported $6,101 in general payments to Angie Osborn across 184 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Angie Osborn did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Angie Osborn come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Angie Osborn

Psychiatric/Mental Health · Yukon, OKNPI 1104522697

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $4,984 of the $6,101 with a category attached, or 81.7%. 10 manufacturers reported payments, led by Johnson & Johnson at 46.6% of the total. 2025 is the largest year on record at $3,299, 2.7 times the $1,218 reported in 2023.

$6,101in general payments, 2019–2025

Across 184 payments — averaging $33.16 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Johnson & Johnson$3K
AbbVie$1K
Otsuka America Pharmaceutical, Inc.$904
Lundbeck LLC$263
Axsome Therapeutics, Inc.$260
Teva Pharmaceuticals USA, Inc.$258
plus $273 from 4 others

What the payments were for

Travel & lodging$91315%
Food & beverage$4,98482%
Education$2033%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Johnson & Johnson	45	$2,845
AbbVie	71	$1,298
Otsuka America Pharmaceutical, Inc.	37	$904
Lundbeck LLC	12	$263
Axsome Therapeutics, Inc.	8	$260
Teva Pharmaceuticals USA, Inc.	6	$258
Supernus Pharmaceuticals, Inc.	1	$117
Sage Therapeutics, LLC	2	$113
Shield Therapeutics Inc	1	$22
Idorsia Pharmaceuticals US Inc	1	$20

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$6,101 in reported general payments places this provider in the 85th percentile of 231 psychiatric/mental health providers in Oklahoma.

See all psychiatric/mental health providers in Oklahoma →

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Desvenlafaxine Succinate ErDesvenlafaxine Succinate	15	$459
Propranolol Hcl	28	$242
Clonazepam	20	$215
Bupropion XlBupropion Hcl	11	$144

Paid to pharmacies, not to this prescriber.

Other psychiatric/mental health in Yukon

Meryl AaronEdmond$23K
Fernanda CooleyTulsa$16K
Amy BoggsNorman$15K
Amber BrownEdmond$15K
Sylvie MawohOklahoma City$14K
Nicole HolzerNorman$12K
Pramila TraxlerTulsa$12K
Sasha LounmalaMuskogee$10K
Sabrina ConleyTulsa$10K
Laura HallNorman$10K

See the full list for Oklahoma →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →